ALB and acute kidney injury: Hyperoncotic human albumin reduced the incidence of AKI by 76% (OR 0.24; CI 0.12 to 0.48, p < 0.0001), while the onset of AKI after hyperoncotic HES significantly increased by 92% (OR 1.92, CI 1.31 to 2.81, p = 0.0008).